Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20091
20112
20131
20141
20155
20161
20183
20202
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Terminated4
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
GlaxoSmithKline2
AIO-Studien-gGmbH1
AbbVie1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Isarna Therapeutics GmbH1
Juergen Debus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms24
Melanoma6
Breast Neoplasms5
Glioblastoma5
Astrocytoma4
Carcinoma, Non-Small-Cell Lung3
Glioma3
Diffuse Intrinsic Pontine Glioma2
Neoplasms2
Oligodendroglioma2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.